Cargando…
Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
BACKGROUND: Spinal muscular atrophy (SMA) is an autosomal recessive disorder that affects the motoneurons of the spinal anterior horn, resulting in hypotonia and muscle weakness. The disease is caused by deletion or mutation in the telomeric copy of SMN gene (SMN1) and clinical severity is in part d...
Autores principales: | Darbar, Illora A, Plaggert, Paulo G, Resende, Maria Bernadete D, Zanoteli, Edmar, Reed, Umbertina C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078847/ https://www.ncbi.nlm.nih.gov/pubmed/21435220 http://dx.doi.org/10.1186/1471-2377-11-36 |
Ejemplares similares
-
Air stacking: effects on pulmonary function in patients
with spinal muscular atrophy and in patients with congenital muscular dystrophy,
por: Marques, Tanyse Bahia Carvalho, et al.
Publicado: (2014) -
Cognitive performance of children with spinal muscular atrophy: A
systematic review
por: Polido, Graziela Jorge, et al.
Publicado: (2019) -
The Effects of Omega-3 Fatty Acid Supplementation on Dexamethasone-Induced Muscle Atrophy
por: Fappi, Alan, et al.
Publicado: (2014) -
Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
por: Machado, Darlene L, et al.
Publicado: (2012) -
Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)